Click below to learn more about the exciting milestones Clarity achieved in the last quarter and our plans for future development as we continue to move closer to our ultimate goal of improving treatment outcomes for children and adults with cancer. #biotech #radiopharmaceuticals #TCT
Clarity Pharmaceuticals’ Post
More Relevant Posts
-
Discover the meaning behind the #IN8bio logo and name! In our latest video, our CEO, William Ho, shares the inspiration and significance. Learn how our focus on #GammaDeltaTCells is driving innovative cancer therapies. Please join us as we push the boundaries of science and work towards #CancerZero or the complete and safe elimination of all tumor cells! #Biotech #CancerResearch #Healthcare #BioPharma #LifeSciences #ClinicalResearch
-
Boundless Bio Reports First Patient Dosing with BBI-825 in the P-I/II Study for Cancer Treatment #boundlessbio #bbi825 #cancer #clinicaltrial #solidtumors #colorectalcancer #phase1/2 #safety #efficacy #antitumoractivity #treatment
Boundless Bio Doses First Patient with BBI-825 in the P-I/II Study for Cancer Treatment
pharmashots.com
-
If you missed our webinar, A New Frontier in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Biomarker Testing, you can view it with the link below. The webinar explores the role cfHPV-DNA plays in cancer prognosis, and what barriers biopharma companies face in incorporating cfHPV-DNA into their clinical trial design. The speakers discuss how pharma manufacturers, HCPs and patients can collaborate to help overcome these barriers. #HPV #CancerResearch https://hubs.la/Q02kBkYH0
-
-
In case you missed our webinar, A New Frontier in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Biomarker Testing, you can view it with the link below. The webinar explores the role cfHPV-DNA plays in cancer prognosis, and what barriers biopharma companies face in incorporating cfHPV-DNA into their clinical trial design. The speakers discuss how pharma manufacturers, HCPs and patients can collaborate to help overcome these barriers. #HPV #CancerResearch https://hubs.la/Q02kM-g50
-
-
Dear #Linkedinfamily EU approves AstraZeneca’s Tagrisso with addition of chemotherapy as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer Click the Link Below for More & Detailed Info: https://lnkd.in/gYjHrtT5 Follow us for real-time updates and in-depth analysis. Lifescience Intellipedia Pvt. Ltd. Clival Database #lifescienceintellipedia #lifesciences #clival #clivaldatabase #daily #new #PharmaNews #PharmaUpdates #BiotechNews #PharmaInnovation #PharmaResearch #MedicalResearch #PharmaIndustry #NewMedication #PharmaTrends #Biopharma #PharmaTech
-
-
⏰ TOMORROW: Don’t miss your opportunity to engage live with the principal curator behind COSMIC Actionability! Join us tomorrow, March 7 at 11 a.m. EST / 4 p.m. GMT for an exclusive interactive webinar featuring Dr. Steve Jupe, COSMIC Actionability's principal curator and Dr. Kyle Nilson, field software trainer at QIAGEN Digital Insights. In this webinar, you’ll explore a series of use cases demonstrating how #cancer and #biopharma labs like yours can harness @Catalogue Of Somatic Mutations In Cancer (COSMIC), to: ● Evaluate genomic loci using COSMIC’s comprehensive coding and non-coding variant annotations. ● Integrate variants with curated findings and summaries of mutational impact and clinical actionability. ● Use mutational signatures for potential clinical diagnosis and drug development applications. Hurry—there’s still time, register now! Can’t make it at this time? Don’t worry. Register now and we’ll send you the on-demand recording as soon as its available. #drugdevelopment #precisiononcology https://lnkd.in/dfrPfgRx
Using COSMIC to predict, identify, and avoid mutational consequences of cancer therapies during early drug development and in patients
event.on24.com
-
#WorldCancerDay 🌍 Our Chief Medical Officer, Sonia Quaratino, speaks on World Cancer Day. In this captivating episode, she shares enlightening perspectives on cancer treatments and how Innate Pharma continues to innovate to bring solutions to patients 💪 #InnatePharma #CancerResearch #MedicalInnovation
-
Precision medicine requires biomarkers and patient screening tools to detect those markers. For innovative biological & immune cell therapies that target cancer-specific peptides presented on germline HLA (surface of cancer cells), highly specific & sensitive genomic tests already exist (two of which are already CE marked in Europe) From a scientific and cost effectiveness perspective, this is one wheel which does not require to be reinvented for clinical trials or commercial launches The purpose of this is co-operative endeavour between transatlantic oncology companies is to move the dial with regulatory agencies so patients can benefit from these precision cancer medicines faster
At @CDR-Life, we support the effort to update the regulatory framework in Europe for #HLA testing. This will facilitate the development of innovative and personalized cancer therapeutics, based on #TCR and TCR mimicking technology, for better patient outcomes. Link to Nature Comms Letter. https://lnkd.in/dGAWUqHh
-
-
Dear #Linkedinfamily EU approves AstraZeneca’s Tagrisso with addition of chemotherapy as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer Click the Link Below for More & Detailed Info: https://lnkd.in/gYjHrtT5 Follow us for real-time updates and in-depth analysis. Lifescience Intellipedia Pvt. Ltd. Clival Database #lifescienceintellipedia #lifesciences #clival #clivaldatabase #daily #new #PharmaNews #PharmaUpdates #BiotechNews #PharmaInnovation #PharmaResearch #MedicalResearch #PharmaIndustry #NewMedication #PharmaTrends #Biopharma #PharmaTech
-
-
Excellent overview of ADC target selection from Pythia Bio!
Among the most exciting advancements in cancer therapeutics are #AntibodyDrugConjugates (ADCs). Wondering what they are, how they work, and what makes a good target for ADCs? Check out our latest blog post below to explore the so-called "biological missile" and 5 tips to find an ideal ADC target! 👉 Read full blog here: https://lnkd.in/gpp_u7d5
-
